Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative sleep quality in elderly thoracic surgery patients
ChiCTR2300074936Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Total sleep duration on the night of surgery. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2300074936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074936.